Research

Peer-reviewed publications

Below is a selected list of my publications. See my Google Scholar profile for the complete list.

Methodology

  1. Cribb, L., Moreno-Betancur, M., Wu, Z., Wolfe, R., Pasé, M., & Ryan, J. (2025). Moving beyond the prevalent exposure design for causal inference in dementia research. The Lancet Healthy Longevity, 6(2), 100675. DOI: 10.1016/j.lanhl.2024.100675.

Applied/Collaborative

  1. Cribb, L., Moreno-Betancur, M., Sarant, J., Wolfe, R., Pase, M. P., Rance, G., Mielke, M. M., Murray, A. M., Owen, A., Woods, R. L., Zhou, Z., Wu, Z., Sheets, K. M., Chong, T. T.-J., Shah, R. C., & Ryan, J. (2026). The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer’s disease and related dementias. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(2), e70397. DOI: 10.1002/dad2.70397.

    Repository

  2. Cribb, L., Moreno-Betancur, M., Pase, M. P., Wolfe, R., Britt, C., Zhou, Z., Shah, R. C., Rance, G., Sheets, K. M., Chong, T. T.-J., Woods, R. L., Murray, A. M., Owen, A., & Ryan, J. (2026). Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia. Neurology, 106(3), e214572. DOI: 10.1212/WNL.0000000000214572.

    Repository

  3. Dowling, N. L., Blair-West, S., Yap, K., Yardley, P., Cribb, L., Clement, S., … & Ng, C. H. (2026). Feasibility and effectiveness of the Bergen 4-Day Treatment for obsessive-compulsive disorder in Australia: A pilot comparison with 3-week inpatient obsessive-compulsive disorder treatment. Australian & New Zealand Journal of Psychiatry, 60(9), 882–893. DOI: 10.1177/00048674261462748.

  4. Young, V. M., Wiedner, C., Baril, A. A., Pase, M. P., Ruiz, A., Salardini, A., … & Seshadri, S. (2026). Non-linear associations between sleep duration and plasma p-tau181 in the Framingham Heart Study. Alzheimer’s & Dementia, 22(5), e71499. DOI: 10.1002/alz.71499.

  5. Sim, M. A., Rowsthorn, E., O’Brien, W. T., Sun, M., Cribb, L., Franks, K., … & Pase, M. P. (2025). Plasma phosphorylated tau-217 correlates with brain atrophy, cognition, and cerebrospinal fluid biomarkers in a cognitively healthy community cohort. Brain Communications, 7(5), fcaf383. DOI: 10.1093/braincomms/fcaf383.

  6. Yiallourou, S. R., Cribb, L., Cavuoto, M. G., Rowsthorn, E., Nicolazzo, J., Gibson, M., … & Pase, M. P. (2024). Association of the sleep regularity index with incident dementia and brain volume. Neurology, 102(2), e208029. DOI: 10.1212/WNL.0000000000208029.

  7. Cribb, L., Sha, R., Yiallourou, S., Grima, N. A., Cavuoto, M., Baril, A. A., & Pase, M. P. (2023). Sleep regularity and mortality: a prospective analysis in the UK Biobank. eLife, 12, RP88359. DOI: 10.7554/eLife.88359.

  8. Cribb, L., Hodge, A. M., Yu, C., Li, S. X., English, D. R., Makalic, E., … & Dugué, P. A. (2022). Inflammation and epigenetic aging are largely independent markers of biological aging and mortality. The Journals of Gerontology: Series A, 77(12), 2378–2386. DOI: 10.1093/gerona/glac147.

Randomised trials

  1. Freijy, T. M., Cribb, L., Oliver, G., Metri, N. J., Opie, R. S., Jacka, F. N., … & Sarris, J. (2023). Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial. Frontiers in Neuroscience, 16, 1097278. DOI: 10.3389/fnins.2022.1097278.

  2. Sarris, J., Byrne, G., Castle, D., Bousman, C., Oliver, G., Cribb, L., … & Ng, C. H. (2022). N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 110550. DOI: 10.1016/j.pnpbp.2022.110550.

  3. Sarris, J., Byrne, G. J., Bousman, C. A., Cribb, L., Savage, K. M., Holmes, O., … & Stough, C. (2020). Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Australian & New Zealand Journal of Psychiatry, 54(3), 288–297. DOI: 10.1177/0004867419891246.

  4. Sarris, J., Byrne, G. J., Stough, C., Bousman, C., Mischoulon, D., Murphy, J., … & Ng, C. H. (2019). Nutraceuticals for major depressive disorder—more is not merrier: An 8-week double-blind, randomised, controlled trial. Journal of Affective Disorders, 245, 1007–1015. DOI: 10.1016/j.jad.2018.11.092.